Results 41 to 50 of about 52,877 (267)

Impact of Long-Term Treatment with Ivermectin on the Prevalence and Intensity of Soil-Transmitted Helminth Infections [PDF]

open access: yes, 2008
Background Control of soil-transmitted helminth (STH) infections relies on the periodic and long-term administration of anthelmintic drugs to high-risk groups, particularly school-age children living in endemic areas.
Oviedo, G   +25 more
core   +1 more source

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial

open access: yesInternational Journal of Antimicrobial Agents, 2022
High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in reducing viral load in individuals with early SARS-CoV-2 infection. This
D. Buonfrate   +17 more
semanticscholar   +1 more source

Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa [PDF]

open access: yes, 2015
River blindness (onchocerciasis) causes severe itching, skin lesions, and vision impairment including blindness. More than 99% of all current cases are found in sub-Saharan Africa.
Remme, JHF   +48 more
core   +2 more sources

RETRACTED: Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

open access: yesPharmacology Research & Perspectives, 2022
Advanced hepatocellular carcinoma (HCC) results in generally poor clinical outcomes and necessitates better therapeutic strategies. Ivermectin, which is an existing anti‐parasitic drug, has been recently identified as a novel anti‐cancer drug.
Haofeng Lu   +7 more
doaj   +1 more source

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

open access: yesInternational Journal of Infectious Diseases, 2020
Ivermectin, an FDA-approved anti-parasitic agent, was found in vitro to inhibit SARS-CoV-2 replication. To determine the rapidity of viral clearance and safety of ivermectin among adult SARS-CoV-2 patients we conducted a randomized, double-blind ...
Sabeena Ahmed   +14 more
semanticscholar   +1 more source

Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. [PDF]

open access: yes, 2009
OBJECTIVE: To generate evidence on the effectiveness of household-wide treatment for preventing the transmission of pediculosis capitis (head lice) in resource-poor communities.
Pilger, Daniel   +11 more
core   +1 more source

Chromatographic Quantification of Ivermectin and Pranziquantel in the Tablets Using Stability Indicating RP-HPLC Method [PDF]

open access: yesPharmaceutical Sciences, 2019
Background: A new stability indicating RP-HPLC based assay method was developed to quantify ivermectin and praziquantel simultaneously and applied effectively to tablets.
Naga Venkata Suresh Kumar Devaka   +1 more
doaj   +1 more source

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype

open access: yesBMC Infectious Diseases, 2022
Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the drug has been widely used in some parts of the world, as shown by impressive market data.
M. Marcolino   +8 more
semanticscholar   +1 more source

Introgression of ivermectin resistance genes into a susceptible Haemonchus contortus strain by multiple backcrossing [PDF]

open access: yes, 2012
Anthelmintic drug resistance in livestock parasites is already widespread and in recent years there has been an increasing level of anthelmintic drug selection pressure applied to parasitic nematode populations in humans leading to concerns regarding the
Elizabeth Redman (183534)   +35 more
core   +1 more source

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19

open access: yesmedRxiv, 2020
Caly et al.1 reported that ivermectin inhibited severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM.
V. Schmith, Jie Zhou, L. Lohmer
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy